Quantcast

Latest Trastuzumab Stories

2011-11-04 12:00:00

Current testing protocols for HER2 amplification may exclude thousands of patients who actually have HER2 gene amplification, delaying or preventing them from receiving potentially life-saving treatment. A new laboratory testing protocol can more accurately identify an important group of breast cancer patients who are most likely to benefit from a âœtargeted therapyâ shown to dramatically improve survival. This recent discovery by PhenoPath Laboratories...

2011-10-07 05:48:08

(Ivanhoe Newswire) -- The future looks bright for patients with HER2-positive breast cancer. A paper published in the October 6, 2011 issue of the New England Journal of Medicine (NEJM), shows that new treatment regimens, providing a lower risk of cardio toxicity, are an acceptable and effective option for patients. The new study, by the Breast Cancer International Research Group, answers a critical question raised by four previously published trials; are adjuvant anthracyclines necessary...

2011-10-06 09:54:37

Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday. The study also found that a regimen without the drug Adriamycin, an anthracycline commonly used as a mainstay to treat breast cancer but one that, especially when paired...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related